Pharmaceutical Packaging and Labelling

Pharmaceuticals and Medical Devices put a strong emphasis on safe, manageable, compliant packaging that maintains the product in its intended state, can be used easily by the consumer/patient and represents the efficiency that companies wish to be associated with their brand. Representing a huge market in itself (it has been estimated that the Pharmaceutical packaging market will increase to $18.2 billion by 2005), packaging and labelling plays a crucial role in the commercial value of a drug or device.

This global Conference aims to take a close look at current and pending regulations governing packaging and labelling and how to ensure compliance. The event hopes to provide an interactive forum whereby representatives from Pharmaceutical and medical device companies, packaging manufacturers/contracters and regulatory authorities can come together to assess the regulations and their impact on the industry.

The event would look at how to communicate information and instructions to the consumer, how best to design packaging, how to ensure it meets the criteria in terms of useability, child resistance and protection from potentially harmful environmental factors. The event will also cover topical issues such as bar coding and will take a look at some of the issues surrounding security.

This event hold a high appeal for anyone trying to stay at the forefront of developments, from technical/engineering issues, to manufacture, from quality assurance and compliance to security and safety. A unique opportunity to learn from leading industry experts including:

Dr Julia Coombes, Senior Assessor Product Information Unit, Medicines & Healthcare Products Regulatory Agency (MHRA) Dr Claudia Okeke, Associate Director, Information & Standards Development, United States Pharmacopeia (USP) Dr Leander Fontaine, Vice President, International Labelling Liaison, Wyeth Barbara Lachmann, Head, Global Labelling, Merck Dr Patty Kiang, Director, Packaging Support, Worldwide Technical Service, Schering-Plough Ralph Dillon, Director, Quality Engineering, Pfizer Dr John Lively, EFPIA Leader, PIM Project, Eli Lilly Dr Francis Petit, Senior Manager, Labelling Europe, Cardiovascular & Insulin Products, Aventis Peter Mayberry, Executive Director, Healthcare Compliance Packaging Council

Benefits of Attending: